Review article · 2024 · Open access

Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine

Qigu Yao, Sheng Cheng, Qiaoling Pan, Jiong Yu, Guoqiang Cao, Lanjuan Li, Hongcui Cao

MedComm, 5(10), e735 · Published 21 September 2024 · DOI 10.1002/mco2.735

Open PDFView at the publisherCite this paper

In brief

“Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine” is a 2024 review article by Qigu Yao and 6 co-authors, published in MedComm. OpenAlex counts 123 citations as of 22 November 2026. It is open access under a CC BY licence: the full text is free to read at MedComm.

Citations
123
Most cited in
2026 (64)
Field-weighted impact
3.39
References
326
Authors
7

Abstract

Organoids are miniature, highly accurate representations of organs that capture the structure and unique functions of specific organs. Although the field of organoids has experienced exponential growth, driven by advances in artificial intelligence, gene editing, and bioinstrumentation, a comprehensive and accurate overview of organoid applications remains necessary. This review offers a detailed exploration of the historical origins and characteristics of various organoid types, their applications-including disease modeling, drug toxicity and efficacy assessments, precision medicine, and regenerative medicine-as well as the current challenges and future directions of organoid research. Organoids have proven instrumental in elucidating genetic cell fate in hereditary diseases, infectious diseases, metabolic disorders, and malignancies, as well as in the study of processes such as embryonic development, molecular mechanisms, and host-microbe interactions. Furthermore, the integration of organoid technology with artificial intelligence and microfluidics has significantly advanced large-scale, rapid, and cost-effective drug toxicity and efficacy assessments, thereby propelling progress in precision medicine. Finally, with the advent of high-performance materials, three-dimensional printing technology, and gene editing, organoids are also gaining prominence in the field of regenerative medicine. Our insights and predictions aim to provide valuable guidance to current researchers and to support the continued advancement of this rapidly developing field.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Yao, Q., Cheng, S., Pan, Q., Yu, J., Cao, G., Li, L., & Cao, H. (2024). Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine. MedComm, 5(10), e735. https://doi.org/10.1002/mco2.735

MLA 9

Yao, Qigu, et al. “Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine.” MedComm, vol. 5, no. 10, 2024, p. e735. https://doi.org/10.1002/mco2.735.

Chicago

Yao, Qigu, Sheng Cheng, Qiaoling Pan, Jiong Yu, Guoqiang Cao, Lanjuan Li, and Hongcui Cao. 2024. “Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine.” MedComm 5 (10): e735. https://doi.org/10.1002/mco2.735.

Harvard

Yao, Q. et al. (2024) ‘Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine’, MedComm, 5(10), p. e735. doi:10.1002/mco2.735.

IEEE

Q. Yao et al., “Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine,” MedComm, vol. 5, no. 10, p. e735, 2024, doi: 10.1002/mco2.735.

BibTeX

@article{yao2024organoids,
  title     = {{Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine}},
  author    = {Yao, Qigu and Cheng, Sheng and Pan, Qiaoling and Yu, Jiong and Cao, Guoqiang and Li, Lanjuan and Cao, Hongcui},
  journal   = {MedComm},
  year      = {2024},
  volume    = {5},
  number    = {10},
  pages     = {e735},
  doi       = {10.1002/mco2.735},
  url       = {https://doi.org/10.1002/mco2.735}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202411
20255858
20266464

Its field-weighted citation impact is 3.39: it has been cited 3.39 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research

  • organoids
  • disease modeling
  • drug discovery
  • precision medicine
  • regenerative medicine
  • drug toxicity assessment
  • drug efficacy evaluation
  • genetic disorders

Work with this paper

Most-cited papers in Engineering

All highly cited Engineering papers

Questions about this paper

How do I cite this paper in APA style?

Yao, Q., Cheng, S., Pan, Q., Yu, J., Cao, G., Li, L., & Cao, H. (2024). Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine. MedComm, 5(10), e735. https://doi.org/10.1002/mco2.735

How many times has this paper been cited?

123 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at MedComm: sign in and open the PDF from this page.

Who wrote this paper?

Qigu Yao, Sheng Cheng, Qiaoling Pan, Jiong Yu, Guoqiang Cao, Lanjuan Li, Hongcui Cao.

What is the DOI of this paper?

10.1002/mco2.735, permanently at https://doi.org/10.1002/mco2.735. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.